Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation

Abstract

Sarcopenia affects 15% of patients with stable COPD and impairs function and health status. Sarcopenia does not impact on response to PR, which can lead to a reversal of the syndrome in select patients.